These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1822830)

  • 21. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.
    Chabot-Fletcher MC; Underwood DC; Breton JJ; Adams JL; Kagey-Sobotka A; Griswold DE; Marshall LA; Sarau HM; Winkler JD; Hay DW
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1147-55. PubMed ID: 7791085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
    Richwien A; Wurm G
    Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands.
    Ospelt C; Kurowska-Stolarska M; Neidhart M; Michel BA; Gay RE; Laufer S; Gay S
    Ann Rheum Dis; 2008 Apr; 67(4):524-9. PubMed ID: 17666446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM
    J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents.
    Pontiki E; Hadjipavlou-Litina D
    Bioorg Med Chem; 2007 Sep; 15(17):5819-27. PubMed ID: 17604175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
    Carlson RP; O'Neill-Davis L; Calhoun W; Datko L; Musser JH; Kreft AF; Chang JY
    Agents Actions; 1989 Mar; 26(3-4):319-28. PubMed ID: 2500009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
    Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
    J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of S-4-(3-thienyl)phenyl-alpha-methylacetic acid.
    Mittal S; Malde A; Selvam C; Arun KH; Johar PS; Jachak SM; Ramarao P; Bharatam PV; Chawla HP
    Bioorg Med Chem Lett; 2004 Feb; 14(4):979-82. PubMed ID: 15013005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WY-50295 tromethamine: a 5-lipoxygenase inhibitor without activity in human whole blood.
    Carlson R; Kreft A; Hartman D; Tomchek L; Lock Y; Weichman B; Glaser K
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):31-41. PubMed ID: 10319915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
    J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow.
    Ulbrich H; Soehnlein O; Xie X; Eriksson EE; Lindbom L; Albrecht W; Laufer S; Dannhardt G
    Biochem Pharmacol; 2005 Jul; 70(1):30-6. PubMed ID: 15894291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperazinealkanol ester derivatives of indomethacin as dual inhibitors of 5-lipoxygenase and cyclooxygenase.
    Yamawaki I; Suzuki M; Ogawa K
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):963-71. PubMed ID: 8020132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal antiinflammatory agents, XVIII: C-5 functionalized 6,7-diphenyl-2,3-dihydro-1H-pyrrolizines as inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W
    Arch Pharm (Weinheim); 1994 Aug; 327(8):509-14. PubMed ID: 7944906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of leukotriene production by N-[4-[4-(diphenylmethyl)-1- piperazinyl]butyl]-3-(6-methyl-3-pyridyl) acrylamide (AL-3264), a new antiallergic agent.
    Ishii K; Yakuo I; Motoyoshi S; Nakagawa H; Nakamura H
    Jpn J Pharmacol; 1994 May; 65(1):19-25. PubMed ID: 7916384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
    Glaser KB; Carlson RP; Sung A; Bauer J; Lock YW; Holloway D; Sturm R; Hartman D; Walter T; Woeppel S
    Agents Actions; 1993; 39 Spec No():C30-2. PubMed ID: 8273577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.